BCR and B-cell chronic lymphocytic leukemia: A possible explanation may be that CD40 acts as a gatekeeper for BCR signaling by inhibiting negative feedback components like LYN and SHP-1, so that CD40-dependent activation of the BCR pathway is required to overcome negative feedback signals in anergic CLL cells (119) (Figure 3).